Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
23.60
-0.17 (-0.72%)
At close: Dec 17, 2025, 4:00 PM EST
23.61
+0.01 (0.04%)
After-hours: Dec 17, 2025, 7:00 PM EST
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.88B EUR in the quarter ending September 30, 2025, with 0.01% growth. This brings the company's revenue in the last twelve months to 19.64B, up 1.44% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.60%.
Revenue (ttm)
19.64B EUR
Revenue Growth
+1.44%
P/S Ratio
0.59
Revenue / Employee
176,147 EUR
Employees
111,513
Market Cap
13.50B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.34B | -117.62M | -0.60% |
| Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
| Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
| Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
| Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
| Dec 31, 2019 | 17.48B | 929.68M | 5.62% |
| Dec 31, 2018 | 16.55B | -1.24B | -6.95% |
| Dec 31, 2017 | 17.78B | 1.21B | 7.33% |
| Dec 31, 2016 | 16.57B | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | 13.08B | 2.46B | 23.16% |
| Dec 31, 2013 | 10.62B | 162.03M | 1.55% |
| Dec 31, 2012 | 10.46B | 751.40M | 7.74% |
| Dec 31, 2011 | 9.71B | 695.09M | 7.71% |
| Dec 31, 2010 | 9.02B | 1.17B | 14.93% |
| Dec 31, 2009 | 7.84B | 229.27M | 3.01% |
| Dec 31, 2008 | 7.61B | 964.95M | 14.51% |
| Dec 31, 2007 | 6.65B | 190.66M | 2.95% |
| Dec 31, 2006 | 6.46B | 728.04M | 12.70% |
| Dec 31, 2005 | 5.73B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
FMS News
- 7 days ago - Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board - PRNewsWire
- 22 days ago - Fresenius Medical Care: 'Buy' Again Following A Peak In May - Seeking Alpha
- 6 weeks ago - Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 - PRNewsWire
- 6 weeks ago - Fresenius Medical Care beats quarterly profit estimates helped by cost cuts - Reuters
- 6 weeks ago - Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 - PRNewsWire
- 2 months ago - Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement - PRNewsWire
- 3 months ago - Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - PRNewsWire